Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple‐negative breast cancer

Delayed time to chemotherapy (TTC) is associated with decreased outcomes of breast cancer patients. Recently, studies suggested that the association might be subtype‐dependent and that TTC within 30 days should be warranted in patients with triple‐negative breast cancer (TNBC). The aim of the curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Heeg, Erik, Marang‐van de Mheen, Perla J., Van Maaren, Marissa C., Schreuder, Kay, Tollenaar, Rob A.E.M., Siesling, Sabine, Bos, Monique E.M.M., Vrancken Peeters, Marie‐Jeanne T.F.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317578/
https://www.ncbi.nlm.nih.gov/pubmed/31721193
http://dx.doi.org/10.1002/ijc.32788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317578/
https://www.ncbi.nlm.nih.gov/pubmed/31721193
http://dx.doi.org/10.1002/ijc.32788

Ejemplares similares